Cited 0 time in
ANA-negative Antitopoisomerase I Antibody Is Not Generally Accepted
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jearn, La-He | - |
| dc.contributor.author | Kim, Think-You | - |
| dc.date.accessioned | 2022-07-10T15:03:26Z | - |
| dc.date.available | 2022-07-10T15:03:26Z | - |
| dc.date.created | 2021-05-12 | - |
| dc.date.issued | 2019 | - |
| dc.identifier.issn | 0315-162X | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/148686 | - |
| dc.language | 영어 | - |
| dc.language.iso | en | - |
| dc.publisher | J RHEUMATOL PUBL CO | - |
| dc.title | ANA-negative Antitopoisomerase I Antibody Is Not Generally Accepted | - |
| dc.type | Article | - |
| dc.contributor.affiliatedAuthor | Jearn, La-He | - |
| dc.identifier.doi | 10.3899/jrheum.190524 | - |
| dc.identifier.scopusid | 2-s2.0-85074446494 | - |
| dc.identifier.wosid | 000493976000024 | - |
| dc.identifier.bibliographicCitation | JOURNAL OF RHEUMATOLOGY, v.46, no.11, pp.1546 | - |
| dc.relation.isPartOf | JOURNAL OF RHEUMATOLOGY | - |
| dc.citation.title | JOURNAL OF RHEUMATOLOGY | - |
| dc.citation.volume | 46 | - |
| dc.citation.number | 11 | - |
| dc.citation.startPage | 1546 | - |
| dc.type.rims | ART | - |
| dc.type.docType | Letter | - |
| dc.description.journalClass | 1 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.identifier.url | https://www.jrheum.org/content/46/11/1546 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
